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Abstract
Background: Pediatric hydrocephalus is a devastating and costly disease. The mainstay of treatment is still surgical
shunting of cerebrospinal fluid (CSF). These shunts fail at a high rate and impose a significant burden on patients, their
families and society. The relationship between clinical decision making and shunt failure is poorly understood and
multifaceted, but catheter occlusion remains the most frequent cause of shunt complications. In order to investigate
factors that affect shunt failure, we have established the Wayne State University (WSU) shunt biobank.
Methods: To date, four hospital centers have contributed various components of failed shunts and CSF from patients
diagnosed with hydrocephalus before adulthood. The hardware samples are transported in paraformaldehyde and
transferred to phosphate-buffered saline with sodium azide upon deposit into the biobank. Once in the bank, they
are then available for study. Informed consent is obtained by the local center before corresponding clinical data are
entered into a REDCap database. Data such as hydrocephalus etiology and details of shunt revision history. All data
are entered under a coded identifier.
Results: 293 shunt samples were collected from 228 pediatric patients starting from May 2015 to September 2019.
We saw a significant difference in the number of revisions per patient between centers (Kruskal–Wallis H test, p
value < 0.001). The leading etiology at all centers was post-hemorrhagic hydrocephalus, a fisher’s exact test showed
there to be statistically significant differences in etiology between center (p = 0.01). Regression showed age (p < 0.01),
race (p = 0.038) and hospital-center (p < 0.001) to explain significant variance in the number of revisions. Our model
accounted for 31.9% of the variance in revisions. Generalized linear modeling showed hydrocephalus etiology
(p < 0.001), age (p < 0.001), weight and physician (p < 0.001) to impact the number of ventricular obstructions.
Conclusion: The retrospective analysis identified that differences exist between currently enrolled centers, although
further work is needed before clinically actionable recommendations can be made. Moreover, the variables collected
from this chart review explain a meaningful amount of variance in the number of revision surgeries. Future work will
expand on the contribution of different site-specific and patient-specific factors to identify potential cause and effect
relationships.
Keywords: Hydrocephalus, Biobank, Shunt failure, Shunt obstruction, CSF = cerebrospinal fluid, Ventriculoperitoneal
shunt, Retrospective cohort, Translational, Multicenter, Improving surgical outcomes
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Background
Pediatric hydrocephalus, a condition caused by altered
cerebrospinal fluid (CSF dynamics), affects approximately
1 in 1100 people in the USA [1]. The perturbation of CSF
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homeostasis can lead to increased ventricular size and
compression of vital brain structures [2]. There are a variety of hydrocephalus etiologies. Those most common
in pediatrics include congenital central nervous system
(CNS) malformations, infection, intraventricular hemorrhage (IVH), genetic defects, trauma, and teratogens
[3]. Risk factors associated with pediatric hydrocephalus
include birth weight less than 1500 grams, prematurity
(gestational age less than or equal to 30 weeks), maternal
diabetes, low socioeconomic status, and male sex. Incidence is lower in Asians than other races [4, 5].
Shunting of CSF from the ventricles became the mainstay of treatment for pediatric hydrocephalus in the
1950s, with ventriculoatrial shunts (VAS) being the preferred configuration. Shunts utilizing valves for CSF
pressure or flow control soon became the norm. In the
1980s the VAS was superseded by the ventriculoperitoneal shunt (VPS) for hydrocephalus management. In the
1990s endoscopic third ventriculostomy (ETV) became
an option to manage some types of obstructive hydrocephalus, obviating the need for fallible shunt hardware
[6]. In 2005 and again in 2012, the National Institutes of
Health sponsored an expert panel to discuss priorities
for hydrocephalus research, this panel concluded both
times that current methods of diagnosis, treatment and
outcome monitoring need improvement [7, 8]. More
recently, the Hydrocephalus Clinical Research Network
(HCRN), a consortium of 14 North American Pediatric
Hospitals, developed a standardized operating protocol
that was shown to reduce rates of post-operative infection associated with shunt procedures [9].
Pediatric CSF shunt systems have a failure rate of up to
85% within 10 years from initial insertion [10, 11]. Annual
hospitalizations for hydrocephalus have reached 70,000
per year in the USA. Nearly all patients with hydrocephalus (98%) will experience shunt failure in their lifetime
[12]. Pediatric patients experience higher rates of failure,
with 40% of shunts failing within 2 years of implantation
[13]. The annual cost of pediatric hydrocephalus intervention is approximately $195.5–204.5 million [14] and
the overall burden to the healthcare system is between
$1.4 and 2.0 billion; over half of these expenses are due to
shunt revisions [15].
Tissue obstruction of the proximal (i.e. ventricular)
catheter is the main source of failure in VPS systems,
accounting for approximately 50% of failures within the
pediatric population [16]. The mechanisms underlying
this failure are still poorly understood. Sekhar et al. [17]
provided the earliest description of the cell types involved
in shunt catheter occlusion, and more recent efforts have
shown that astrocytes and microglia likely play a central role in this tissue obstruction [18]. The molecular
pathways underpinning this phenomenon, which could
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serve as targets for pharmacologic intervention, are not
yet known. Likewise, there is a lack of understanding as
to how clinical decision-making influences shunt failure
rates. With the new opportunities offered by cheaper
sequencing and tissue-clarification, the field stands
poised to gain a deeper understanding of the biological
processes underlying shunt failure due to obstruction.
To facilitate investigation of this question, we created a
national biorepository of all failed shunt hardware, following other institutions that have created biobanks for
different medical conditions [19, 20]. Centered at Wayne
State University (WSU), this shunt biobank and corresponding clinical database has the potential to be a global
cohort of explanted central nervous system hardware.
In this paper, the authors set out to detail the biobank
and demonstrate how participating centers can benchmark their performance against others. Moreover, by
modeling the effects of collected variables on the number
of revisions, this paper attempts to build the foundation
for prognostic algorithms—something which has been
lacking for pediatric hydrocephalus.

Materials and methods
Ethics approval and study population

Written informed consent was obtained from all patients
or their legally authorized representative. The patient
population includes a vulnerable group (children), but
the study is aimed at addressing the health needs of this
group and cannot be conducted in a non-vulnerable
group. The biobank has samples from individuals who
were aged between 36 days and 42 years, with a mean
of 9.23 years (SD = 8.39). Samples were collected from
individuals with any hydrocephalus etiology except normal pressure hydrocephalus and with any clinical history. Patients were evaluated by local centers according
to their individual guidelines, and samples were only
collected if the shunt malfunction indicated surgical
intervention.
Current centers

Children’s Hospital of Michigan and Wayne State University (WSU), St. Louis Children’s Hospital and Washington University School of Medicine in St. Louis (WUSM),
Texas Children’s Hospital -Baylor College of Medicine
(TEX), Riley Children’s Hospital—Indiana University
Health (RC), the Children’s Hospital of Alabama at University of Alabama Birmingham (ALA), and John’s Hopkins Medicine (JHU). ALA and JHU had not contributed
samples at the time of analysis.
Sample collection

After removal by a surgeon, the shunt samples were
placed in a solution of sterile 4% (w/v) paraformaldehyde
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(PFA). They were then given a unique identifier and deidentified to those who performed the analyses. Samples
were shipped to the coordinating center at room temperature. Upon arrival, the shunt components were changed
to a solution of 1X PBS with 0.01% (w/v) Sodium Azide
and stored at 4 °C. The solution was refreshed monthly.
For the samples associated with CSF, this was collected
intraoperatively: most commonly during final testing
of the shunt dynamics. If CSF was collected, the time
elapsed between collection and processing was noted.
The CSF was kept below 4 °C until it was spun down at
1000 g for 6 min. The supernatant was then aliquoted
into 1.5 mL Eppendorf polypropylene microcentrifuge
tubes. The supernatant was stored at − 80 °C and the cell
pellet was stored in liquid nitrogen.
Once a patient is enrolled in the study, a review of all
their operative reports is performed in order to gather
their history of shunt revisions. Some of the clinical variables collected were hydrocephalus etiology, demographics, suspected cause for hardware removal, physician
performing procedure, shunt configuration, whether the
catheter was adherent to a ventricular wall or the choroid
plexus, number of prior revisions, number of ventricular
catheters, and number of ventricular catheter obstructions. New variables were created in REDCap using
the subtraction of dates; for example, length of hardware implantation = date of surgery – date of hardware
implantation. Additional file 1: Table S1 shows all the
variables collected. Hydrocephalus etiology was determined by the pre-existing protocols practiced by each
center’s neurosurgeons and neuroradiologists.
In order to determine our collection rate, the total
number of procedures performed at each center during
the dates of collection were obtained from de-identified
departmental records.
Statistical analysis

SPSS for Windows version 25.0 was used. The Chi square
test was used to check for differences in race between
patients and census data for the metropolitan areas
where our centers are located. Fisher’s exact test was
used to check for differences in hydrocephalus etiologies between centers. The Kruskal–Wallis test was used
to determine if significant differences existed between
study groups. Dunn’s post hoc test was used for pairwise
comparisons. Hierarchical linear regression was used to
determine the amount of variance explained by variables
on the total number of revisions. The dependent variables were made ready for analysis by a square root transformation. Only the first sample collected from patients
was used in regression analysis. Residuals were plotted to
assess normality and Cook’s distance was used to check
for cases that disproportionately skewed the model.
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Effects in the models were checked for collinearity. Generalized Linear modeling was used to model the effects
of similar variables on the number of ventricular obstructions, the residuals and Cook’s distance were checked to
validate the model.
Clinical database

Study data were collected and managed using REDCap
electronic data capture tools hosted at Wayne State University [21, 22]. REDCap (Research Electronic Data Capture) is a secure, web-based software platform designed
to support data capture for research studies. Each participating center is responsible for the collection and maintenance of their data. All centers can access the entirety
of the clinical data in our REDCap database.

Results
Current biobank content

Across these 4 centers, to date we have enrolled 228 pediatric-hydrocephalus patients, from whom 293 samples
have been collected (Table 1); the majority come from
WSU and WUSM and most (75.4%) included a proximal catheter. The collection rates (Table 1) vary between
centers and from year to year, with a total colleciton rate
of 21%. Records for the total number of revision procedures at WUSM were missing from 2015 and incomplete
in 2016.
The demographics of the patients already enrolled
(Table 2) show a prevalence of males; however, this was
not statistically significant. The total percentage of African American patients was significantly higher compared to the general population (Chi square p = 0.0013);
however, this significance disappears when controlling
for the percentage of African Americans in the metropolitan areas our hospitals serve (Chi square p = 0.8278).
Patient age at sample collection was significantly different
between the sites (Kruskal–Wallis H test p < 0.001).
Hydrocephalus history

The hydrocephalus etiologies (Table 3) of patients in our
biobank varied significantly between centers (Fisher’s
Exact Test p = 0.01); however, the leading etiology at all
centers was intraventricular hemorrhage of prematurity.
The most commonly suspected cause for hardware
removal (Table 4) was obstruction of the proximal catheter, with 41.2% of samples having it as the sole suspected
cause of failure. One notable finding was that while valve
obstruction and disconnection each accounted for a
small number of samples where they were the sole cause
for removal (3.4% and 2.4% respectively); however, both
were commonly included when multiple causes of failure
were suspected.
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Table 1 Current biobank content
Center
WSU

WUSM

TEX

RC

Total

Number of patients

73

109

34

12

228

Number of samples

113

132

34

14

293

Number of samples associated with CSF

40

36

–

–

76

Mean samples per patient

1.58

1.21

1.00

1.17

1.29

Sample breakdown by hardware type
Samples which include a ventricular catheter

101

81

28

11

221

Samples which include a valve

2

88

5

1

96

Samples which include a peritoneal catheter

2

33

4

1

40

Samples which include an EVD

5

1

–

–

6

Samples which include a subdural catheter

3

5

–

–

8

Samples which include a reservoir

1

14

–

1

16

Number of samples per year
2015

–

24

–

–

24

2016

49

15

–

–

64

2017

32

27

1

–

60

2018

28

37

23

1

89

2019

5

29

10

12

56

Collection rates as a percentage of total revision surgeries performed
2015

–

Missing

–

–

–

2016

31%

Missing

–

–

–

2017

15%

42%

3%

–

20%

2018

19%

43%

15%

33%

22%

2019

7%

46%

7%

28%

18%

The character “–” denotes a cell whose value is zero CSF cerebrospinal fluid EVD external ventricular drain

Table 2 Demographics of patients with samples in the biobank

Data represent counts of patients unless otherwise denoted. Percentages were calculated down the column for each variable, illustrated with the darker cell borders.
The character “–”represents a cell whose value is zero, SD standard deviation
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Table 3 Hydrocephalus etiology

Observed refers to the counts of patients with each etiology. Expected refers to the expected frequency of each etiology if there were not differences between the
centers CNS central nervous system LCAM1 L1 cell adhesion molecule

When the indication for failure included infection, we
cross referenced lab results to check if the patient had a
positive CSF culture during their admission. Out of the
29 samples that were removed for suspected infection: 6
had negative CSF cultures, 20 had positive cultures and
no cultures were ever obtained for 3. Additionally, 4 others in whom infection was not suspected pre-operatively
showed positive CSF cultures.
The number of revisions prior to patient enrollment
in the biobank (Fig. 1a) differed significantly between
centers (Kruskal–Wallis H test p < 0.001); the medians
(and interquartile ranges) are as follows: WSU 3 (8),
WUSM 1 (3), TEX 1 (1), and RC 1 (4). Pairwise comparisons (Dunn’s post hoc test) showed WSU to be significantly higher than TEX and WUSM (p = 0.003 and
p < 0.001 respectively). All other comparisons were not
significant. The number of ventricular catheter obstructions prior to enrollment (Fig. 1b) was also significantly different between centers (Kruskal–Wallis H test
p < 0.001). Pairwise comparison (Dunn’s post hoc test)
showed WUSM to be significantly lower than TEX and
WSU (p < 0.001 and p < 0.001 respectively), all other
comparisons were not significant. One other metric
by which centers can be compared is the mean length
of time that each ventricular catheter was implanted

before failing (Fig. 2). The median lengths of insertion in months (and interquartile ranges) were as follows: WSU 5.84 (52.08), WUSM 8.97 (64.54), TEX 8.61
(55.16), and RC 8.01 (42.48). There was not a significant
difference between the centers (Kruskal–Wallis H test
p = 0.609).
Hierarchical linear regression was performed to see if
site, and other variables, significantly impacted the number of revisions prior to enrollment when controlling for
sex, age at surgery, race, ethnicity, and weight. The R2 of
these controlled variables was .226, with age having significant (p < 0.001) positive correlation. Race also significantly (p = 0.038) affected the number of revisions; the
only significant pairwise comparison (Dunn’s post hoc
p = 0.04) showed African Americans to have had more
revisions than Caucasians. No other control variables
reached significance. The predictor variables included
in the model were site, shunt configuration (VPS, VAS,
LPS etc.), hydrocephalus etiology, reason for removal,
and physician performing the operation. The total R
 2 of
2
the model was .319, thus the R change due to the predictor variables was .093 with site having a significant effect
(p < 0.001). Notably, hydrocephalus etiology (p = 0.493),
shunt configuration (p = 0.070), and physician (p = 0.706)
did not reach significance.
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Table 4 Suspected cause for hardware removal
Number of samples with only one suspected
cause of failure (% of total samples)
Proximal catheter obstruction
Valve obstruction

Number of samples,
including multiple suspected causes
(% of total samples)

121 (41.2)

148 (50.5)

10 (3.4)

31 (10.6)

Multiple suspected causes

37 (12.6)

NA

Externalization due to infection

26 (8.9)

29 (9.9)

Internalization to remove EVD

20 (6.8)

20 (6.8)

9 (3.1)

15 (5.1)

Distal catheter obstruction

7 (2.4)

15 (5.1)

Switching shunt configuration

Disconnection

11 (3.8)

11 (3.8)

Removal of original reservoir

10 (3.4)

10 (3.4)

6 (2.0)

8 (2.7)

Over-drainage
Reservoir malfunction

4 (1.4)

6 (2.0)

Truncated catheter

4 (1.4)

4 (1.4)

Unknown

4 (1.4)

4 (1.4)

Upgrading valve

4 (1.4)

4 (1.4)

Fracture of proximal catheter

2 (0.7)

4 (1.4)

No longer shunt dependent

4 (1.4)

4 (1.4)

Fracture of distal catheter

2 (0.7)

3 (1.0)

Externalized due to other cause

2 (0.7)

3 (1.0)

Ventriculomegaly not otherwise specified

3 (1.0)

3 (1.0)

Wound dehiscence

3 (1.0)

3 (1.0)

Externalization due to pseudocyst

2 (0.7)

2 (0.7)

Successful ETV

1 (0.3)

1 (0.3)

Pseudo-meningocele formed around valve

1 (0.3)

1 (0.3)

The counts of samples with each suspected cause of failure are shown. The first column displays Multiple suspected causes as its own category, while in the second
column this category has been broken into component causes. (% of total samples) = (n of cause)/(293) ETV endoscopic third ventriculostomy EVD external ventricular
drain NA not applicable

Similar modeling was not valid when performed on
the number of ventricular obstructions due to the
non-normality of the residual plots (data not shown),
therefore generalized linear modeling was used.
Hydrocephalus Etiology (p < 0.001), physician performing the operation (p < 0.001), patient weight at
admission (p = 0.004) and age (p < 0.001) had significant effects. When examining the parameter effects for
hydrocephalus etiology post-hemorrhagic (p < 0.001),
myelomeningocele (p < 0.001), aqueductal stenosis
(p = 0.011), Dandy-Walker malformation (p < 0.001),
congenital CNS malformations (p = 0.017), unknown
(p = 0.001), and other (p = 0.023) had positive correlations with ventricular obstruction, the largest of which
was Dandy-Walker malformation. No individual physician reached significance. The effect of weight in the
model showed a negative correlation with the number
of ventricular obstructions, while age showed a positive
correlation.

Discussion
This biobank has a broad range of sample types from
pediatric hydrocephalus patients with various etiologies;
as such, it allows for easy investigation into the prevalence of different etiologies and reasons for failure. As
it stands, our bank shows a lower prevalence of hydrocephalus due to brain tumors than previously reported
[18]. The prevalence across the various causes of failure
was similar to previously reported values [18]. The rate of
failure due to suspected infection was similar to historic
rates, but not as low as during the HCRN study (5.7%) [9].
This is understandable as sample collection for this study
was already underway when that protocol was published,
and its implementation would take some time for centers
to adopt. Additionally, our study shows a persistence of
intraventricular hemorrhage of prematurity as the leading cause of hydrocephalus, despite recent reductions in
the rates of IVH [23, 24]. The most common etiology at
all centers was post-hemorrhagic hydrocephalus. A final
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Fig. 1 Patient History of Revisions and Ventricular Obstructions Reveals Historic Differences Between Sites. a The mean number of prior revisions
are as follows: WSU 8.53, WUSM 1.99, TEX 1.65, and RC 1.64. b The mean number of prior ventricular obstructions are as follows: WSU 2.73, WUSM
0.15, TEX 1.03, and RC 0.36. **** p-value < 0.0001 by Kruskal–Wallis H test. *denotes numeric outliers more than 3 SDs away from the mean for each
center

advantage over previous collections is the multicenter
design, which will increase the generalizability of future
studies and allow for comparisons between centers. The
diversity and generalizability of this biobank are unique
features that increase its utility to fellow researchers.
Significant differences existed between centers for
the primary outcomes of number of revisions and
proximal catheter obstructions. Regression showed

non-modifiable demographic factors and clinical site to
predict revision number. Additionally, hydrocephalus etiology, physician performing the surgery, weight, and age
predicted variance in the number of ventricular obstructions. While this is not immediately actionable in a clinical setting, it does provide prognostic information.
The historic measurements of performance, i.e.
prior revisions and ventricular obstructions, showed a
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Fig. 2 Similar Duration of Ventricular Catheter Implant Between Sites Shows Recent Performance Is More Similar Than Revision History Suggests.
Box and whisker plots showing median and interquartile range overlay scatterplots of the duration each ventricular catheter sample was implanted.
Data is stratified by site and displayed in months. ǂ indicates p = 0.609. *denotes numeric outliers more than 3 SDs away from the mean for each
center

difference between sites; however, duration of implantation for ventricular catheters did not. Since the latter
reflects the most recent surgeries, this implies that the
clinical sites are currently performing more similarly
than in the past.
No other study has attempted to build a prognostic
algorithm for all etiologies of pediatric hydrocephalus.
The lack of prior work in this area is likely due to the
heterogeneity between patients. The number of samples
currently in the bank is not yet sufficient to deal with
this heterogeneity, as shown by the R
 2 = 0.319. Since we
only modeled the effect of the most commonly studied variables, this insufficiency is evidence that a broad
approach will be required to understand these complex
relationships. The initial reason why we elected for a
broad approach was recent studies showing microglia
and astrocytes to compose most of the tissue obstructing proximal catheters and previous collections of failed
shunts did not have variables relating to inflammation
[18, 25]. By casting a wide net during the retrospective
review, this biobank can better serve future studies.
The extensive characterization of revision history is a
component of this broad focus, it is our hope that this will
allow future studies to characterize the biologic impact of
long-term clinical decision making. Moreover, by collecting failed shunt samples longitudinally, we have several
patients for whom multiple samples are banked. This will
allow for intra-patient comparisons during translational

studies. For example, studying how immune responses
adapt to repeated introduction of foreign material in the
CNS.
We invite readers at other hospitals to join as one of
our centers and contribute samples to the biobank. Additionally, we welcome new collaborators to make use of
the current biobank.
We have begun our own ex vivo studies using some
samples from the biobank to better understand proximal obstruction. As a part of our analysis, we are recording the degree of flow volume transport with a buffered
solution column. This, along with cellular imaging, provides a detailed and objective assessment of ventricular
obstruction. We have found that physical obstruction is
not always present when an operative report lists ventricular obstruction as the suspected cause for removal.
This disparity could explain why physician performing
the operation was predictive of the number ventricular
obstructions. By better understanding the adherent cells,
new materials and coatings can be trialed to better repel
them.
The major limitation to our current study was our
collection rate. The low collection rate leaves room for
sampling bias which could have affected the outcomes
reported in this study. Specific information such as
hydrocephalus etiology or revision history could not be
obtained for samples not collected since those patients
had not enrolled in the study. Qualitatively, we observed
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that a high percentage of samples not collected were distal catheters which had fractured and valves which were
obstructed. Therefore, Table 4 likely underestimates
the true prevalence for these causes. This bias could be
explained by the prominence of proximal obstruction
in current literature, lending surgeons to more often
remember to save proximal catheters. In general, there
are two major hurdles for a center in obtaining a high collection rate. The first is working with surgeons to adopt
a new research protocol and collect failed shunts. The
other issue is timely communication to the research team
so that consent can be obtained before the family leaves.
This second issue can be a major hurdle due to emergent
nature of shunt failure.
There is another factor which could affect collection
rates and contribute to unintentional selection bias:
shunts that are clinically found to be obstructed, or otherwise have failed, but are adherent to underlying tissue
and are abandoned in the patient. In our experience, this
represents a very small number of proximal catheters.
Ultimately, we defer to clinical judgement and see this as
a non-modifiable factor until further advances in catheter
material decrease rates of tissue adherence.
In the future, there are two changes which we would
like to institute. The first is to use pre-operative imaging
to determine when a proximal catheter is in contact with
choroid plexus vs a ventricular wall, instead of relying
on the operative report. Understanding this correlation
may lead to new investigative strategies to mechanisms
of shunt obstruction. The second change is to include
additional variables related to long-term medications and
comorbid conditions. Future uses of the clinical data will
take into consideration the finding from this study that
clinical site should be controlled for during regression
analyses until the underlying cause and effect relationships are better understood; additionally, further work is
needed to elucidate why revisions differed between sites.

Conclusion
We have created a biobank for samples from failed
shunt systems in pediatric patients with hydrocephalus for which there is a corresponding database with
clinical variables. Currently 6 centers are participating; however, only 4 were presented in this paper due
to the limited number of samples from 2 newer centers. Among the 4 centers, there were significant differences in patient age and the number of revisions prior
to enrollment in our study; however, the mean interval
between replacement of ventricular catheters did not
vary significantly. Our current model accounted for
31.9% of the variability in the total number of revisions.
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As our N increases, we will be able to add more variables to our model and hopefully account for a larger
amount of variance. The ultimate goal is a prognostic
algorithm.

Supplementary information
Supplementary information accompanies this paper at https://doi.
org/10.1186/s12987-020-00211-6.
Additional file 1: Table S1. Variables collected from electronic medical
record.
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